The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
 
Brian Robin Hu
No Relationships to Disclose
 
Adrian S Fairey
No Relationships to Disclose
 
Anisha Madhav
No Relationships to Disclose
 
Dongyun Yang
No Relationships to Disclose
 
Meng Li
No Relationships to Disclose
 
Susan G. Groshen
No Relationships to Disclose
 
Craig Stephens
Employment - Response genetics
 
Philip Kim
No Relationships to Disclose
 
Navneet Virk
No Relationships to Disclose
 
Lina Wang
No Relationships to Disclose
 
Sue Ellen Martin
No Relationships to Disclose
 
Nicholas Erho
Employment - GenomeDx
 
Elai Davicioni
Employment - GenomeDx
Leadership - GenomeDx
 
Robert B. Jenkins
Patents, Royalties, Other Intellectual Property - Royalites from Abbott Molecular; Royalties from Genome Diagnostics Inc; Royalties from Genome Diagnostics Inc
 
Robert Benjamin Den
No Relationships to Disclose
 
Tong Xu
No Relationships to Disclose
 
Yucheng Xu
No Relationships to Disclose
 
Inderbir S. Gill
Stock and Other Ownership Interests - Hansen Medical
Honoraria - EDAP TMS
Consulting or Advisory Role - Mimic Technologies
 
David I. Quinn
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Fresenius Kabi; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Algeta/Bayer; Astellas Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
Expert Testimony - Medivation; Teva
 
Amir Goldkorn
No Relationships to Disclose